Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0272d70c9ba3abebfdf08dc6b96f1120 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a72550f53763edc1d0d56863e0cc3e76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_469135f4f990cdf21d13ceaa5414c0ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bdce2933b371be3f375d295e5bfb595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a42e97fa09c756b5f55eff80f7201874 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db4c018461bcf26b4bef69483948dbf0 |
publicationDate |
2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101973351-B1 |
titleOfInvention |
Pharmaceutical composition for preventing or treating diabetes comprising an indole derivative as an active ingredient |
abstract |
INDUSTRIAL APPLICABILITY The present invention relates to a method for inhibiting glycogen synthesis in liver cells by inhibiting expression of a core gene of glycogen synthase by an indole derivative represented by formula (1), inhibiting glucagon-induced increase of sugar production, As a result, it is expected that the indole derivative can be usefully used as a pharmaceutical composition for the prevention or treatment of diabetes, and can be applied to the screening of diabetic therapeutic substances and the development of medicines. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102297251-B1 |
priorityDate |
2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |